Functional Mechanism of Neural Control in Post-Concussion Convergence Insufficiency

脑震荡后收敛不足的神经控制功能机制

基本信息

  • 批准号:
    10701701
  • 负责人:
  • 金额:
    $ 63.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-04-01 至 2026-08-31
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract: During the past 6 years, our study team investigated the neural mechanism of typically-occurring convergence insufficiency (TYP-CI), the most common binocular vision disorder in children and young adults (3.4% to 12.7%5–11) leading to 20 publications12–31 with 4 more in review and 6 in preparation. We conducted the only randomized clinical trial (RCT) integrating objective eye movement and fMRI outcome measures, achieving 100% planned enrollment and retention of 100 young adults.28 Our results localized the reduction in functional activity for TYP-CI compared to controls within the oculomotor vermis (OVM) and the cuneus. Functional activity in the OVM and cuneus was significantly correlated to convergence peak velocity providing the first mechanistic identification of these deficits that create significant burden to those afflicted. 23 Our longitudinal results discovered that the neural mechanistic change stimulated by office-based vergence /accommodative therapy (OBVAT) is an increase in the frontal eye field (FEF) and thalamus functional activity. Increased functional activity from the FEF and thalamus significantly correlates to convergence peak velocity. 23,32,33 Results are leading to personalized point-of-care therapies remediating the debilitating symptoms for TYP-CI patients. While our research and results of other RCTs show that OBVAT is the most effective treatment for remediating symptoms and improving vision function in both TYP-CI children 34–36 and adults, 37,38 none of these participants had a history of head injury, a pathology that has been linked to CI. Our research team has demonstrated that the prevalence of CI is higher (38% to 49%) in children 39,40 and adults 41,42 with persistent post-concussive symptoms (PPCS-CI), than in the non-concussed population. Currently, there is no validated treatment for PPCS-CI. This difference in prevalence, mode of onset (longstanding versus sudden onset), and severity of the condition has led to a debate about whether the diagnostic and management procedures effective for TYP-CI should be utilized for PPCS-CI, and strongly suggests that new research is needed to optimize PPCS-CI management. We are uniquely positioned to provide answers to these questions by building on our work establishing the neurofunctional mechanism of TYP-CI and OBVAT administered to TYP-CI. Such research is of great importance because PPCS-CI is associated with debilitating visual symptoms impacting the return to school/sports, 43–47 work, 48–51 or driving. 52 We have identified three significant gaps for the treatment of PPCS-CI that must be addressed to determine its most effective management. First, given the obvious differences in etiology, are there significant differences between TYP-CI and PPCS-CI related to objective eye movement measures (peak velocity, final amplitude, and repeatability) due to underlying neural mechanistic differences? Second, what is the underlying neural mechanism of OBVAT for PPCS-CI compared to TYP-CI? Third, how effective is OBVAT for PPCS-CI and is the dosage of administration different than TYP-CI? This renewal addresses these gaps in clinical science.
项目概要/摘要:在过去的6年里,我们的研究小组研究了 典型性会聚功能不全(TYP-CI)是儿童中最常见的双眼视觉障碍 和年轻人(3.4%至12.7%5-11),导致20篇出版物12 -31,另有4篇在审查中,6篇在准备中。 我们进行了唯一的随机临床试验(RCT)整合客观眼球运动和功能磁共振成像结果 措施,实现100%的计划入学率和保留100名年轻成人。 与对照相比,眼蚓部(OVM)内TYP-CI的功能活性降低, 楔叶OVM和楔叶的功能活动与会聚峰速度显著相关 提供了对这些缺陷的第一次机械识别,这些缺陷给那些受影响的人造成了重大负担。23 我们的纵向研究结果发现,基于办公室的聚散刺激的神经机制的变化, /抑制疗法(OBVAT)是增加额眼场(FEF)和丘脑功能活动。 FEF和丘脑的功能活动增加与会聚峰显著相关 速度23,32,33 结果导致个性化的护理点治疗, TYP-CI患者的症状。而我们的研究和其他RCT的结果表明,OBVAT是最 有效的治疗,以补救症状和改善视力功能的TYP-CI儿童34-36和 37,38这些参与者中没有一个有头部损伤的历史,这是一种与CI有关的病理学。我们 研究小组已经证明,CI的患病率在儿童中较高(38%至49%)39,40, 与非脑震荡人群相比,持续性脑震荡后症状(PPCS-CI)的成年人41,42。 目前,PPCS-CI尚无有效的治疗方法。这种患病率、发病方式 (长期与突然发作),和严重的条件已导致辩论是否 对于PPCS-CI,应采用对TYP-CI有效的诊断和管理程序, 表明,需要新的研究来优化PPCS-CI管理。我们有独特的优势, 通过建立我们的工作,为这些问题提供答案, TYP-CI和OBVAT给予TYP-CI。这种研究是非常重要的,因为PPCS-CI是 与影响返回学校/运动、43-47工作、48-51或驾驶的衰弱性视觉症状相关。52 我们已经确定了治疗PPCS-CI的三个重要差距,必须解决这些差距,以确定其治疗效果。 最有效的管理。首先,鉴于病因上的明显差异,是否存在显著差异 TYP-CI和PPCS-CI之间的差异与客观眼球运动测量(峰值速度,最终幅度, 和重复性)由于潜在的神经机制差异?第二,什么是潜在的神经 与TYP-CI相比,PPCS-CI的OBVAT机制?第三,OBVAT对PPCS-CI的有效性如何, 与TYP-CI不同的给药剂量?这次更新解决了临床科学中的这些空白。

项目成果

期刊论文数量(26)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
OculoMotor Assessment Tool Test Procedure and Normative Data.
A pilot study of disparity vergence and near dissociated phoria in convergence insufficiency patients before vs. after vergence therapy.
Underlying neurological mechanisms associated with symptomatic convergence insufficiency.
  • DOI:
    10.1038/s41598-021-86171-9
  • 发表时间:
    2021-03-22
  • 期刊:
  • 影响因子:
    4.6
  • 作者:
    Alvarez TL;Scheiman M;Morales C;Gohel S;Sangoi A;Santos EM;Yaramothu C;d'Antonio-Bertagnolli JV;Li X;Biswal BB
  • 通讯作者:
    Biswal BB
Comparison of symmetrical prism adaptation to asymmetrical prism adaptation in those with normal binocular vision.
  • DOI:
    10.1016/j.visres.2018.06.004
  • 发表时间:
    2018-08
  • 期刊:
  • 影响因子:
    1.8
  • 作者:
    Santos EM;Yaramothu C;Alvarez TL
  • 通讯作者:
    Alvarez TL
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tara Lynn Alvarez其他文献

Tara Lynn Alvarez的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tara Lynn Alvarez', 18)}}的其他基金

Functional Mechanisms of Neural Control in Convergence Insufficiency
收敛不足的神经控制功能机制
  • 批准号:
    9055702
  • 财政年份:
    2014
  • 资助金额:
    $ 63.3万
  • 项目类别:
Functional Mechanisms of Neural Control in Convergence Insufficiency
收敛不足的神经控制功能机制
  • 批准号:
    8691212
  • 财政年份:
    2014
  • 资助金额:
    $ 63.3万
  • 项目类别:
Functional Mechanisms of Neural Control in Convergence Insufficiency
收敛不足的神经控制功能机制
  • 批准号:
    9728083
  • 财政年份:
    2014
  • 资助金额:
    $ 63.3万
  • 项目类别:
Functional Mechanism of Neural Control in Post-Concussion Convergence Insufficiency
脑震荡后收敛不足的神经控制功能机制
  • 批准号:
    10297371
  • 财政年份:
    2014
  • 资助金额:
    $ 63.3万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 63.3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了